Page 37 - Legend Biotech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

After market withdrawal, GSK touts positive Blenrep combo trial in multiple myeloma

After market withdrawal, GSK touts positive Blenrep combo trial in multiple myeloma
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

Bristol myers squibb pomalystIncyte jakafiJohnson darzalexTakeda velcadeBristol myers squibbLegend biotech

Legend Biotech Corporation (NASDAQ:LEGN) Q3 2023 Earnings Call Transcript

Operator: Good day, ladies and gentlemen. Thank you for standing by. Welcome to Legend Biotech Reports Third Quarter 2023 Financial Results Conference Call.

Kelly shiYing huangGuowei fangJessie yeungGena wangJessica fyeBristol beckmanLori macomberHead of commercial developmentHealth productsNovartis pharmaceuticals corporationGlobal development planClinical service agreementAgency for medicinesMaster technologyLegend biotech corporation

Legend Biotech (NASDAQ:LEGN) Issues Quarterly Earnings Results

Legend Biotech (NASDAQ:LEGN) Issues Quarterly Earnings Results
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

United kingdom generalUnited kingdomUnited statesBridgewater associatesLegend biotech corporationBlackrock incPricet rowe associates incGoldman sachs groupLegend biotechGet free reportMarketwatch earningsBiotech stock downWorld investorsBiotech corporationLegend biotech daily

Legend Biotech (NASDAQ:LEGN) Issues Quarterly Earnings Results, Beats Expectations By $0 14 EPS

Legend Biotech (NASDAQ:LEGN – Get Free Report) issued its quarterly earnings data on Monday. The company reported ($0.17) EPS for the quarter, topping the consensus estimate of ($0.31) by $0.14, MarketWatch Earnings reports. The business had revenue of $96.00 million for the quarter, compared to analyst estimates of $97.25 million. The firm’s revenue was up […]

United statesCoppell advisory solutionsLazard asset managementLegend biotech company profileAmerican international group incLegend biotech corporationGoldman sachs groupFinancial services group incLegend biotechGet free reportMarketwatch earningsServices groupAdvisory solutionsInternational groupBiotech corporationLegend biotech daily

Legend Biotech (NASDAQ:LEGN) Releases Quarterly Earnings Results, Beats Expectations By $0 14 EPS

Legend Biotech (NASDAQ:LEGN – Get Free Report) announced its quarterly earnings results on Monday. The company reported ($0.17) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.31) by $0.14, MarketWatch Earnings reports. The company had revenue of $96.00 million during the quarter, compared to the consensus estimate of $97.25 million. The […]

United statesGoldman sachs groupLegend biotech corporationAmerican international group incFinancial services group incCoppell advisory solutionsLazard asset managementLegend biotechGet free reportMarketwatch earningsServices groupAdvisory solutionsInternational groupBiotech corporationLegend biotech dailyNasdaq legn